STRUCTURE OF HEPATITIS B ANTIGENS
乙型肝炎抗原的结构
基本信息
- 批准号:2060317
- 负责人:
- 金额:$ 11.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-06-01 至 1996-05-31
- 项目状态:已结题
- 来源:
- 关键词:DNA directed DNA polymerase albumins aminoacid analyzer binding proteins chimeric proteins chromatography gel electrophoresis genetic mapping guinea pigs hepatitis B antigens hepatitis B virus group immunochemistry membrane proteins monoclonal antibody oligosaccharides oral administration peptidases phosphorylation posttranscriptional RNA processing posttranslational modifications protein biosynthesis protein sequence protein structure radioimmunoassay receptor binding surface antigens viral vaccines virus DNA virus protein
项目摘要
The first goal of this project is to determine the structures of the
surface proteins of the hepatitis B virus, referred to as the hepatitis B
surface antigen (HBsAg), and to determine the relationship between their
structures and functions both as essential viral proteins and as the
important host targets for prevention of the viral disease. HBsAg is
produced in large amounts during the normal course of HBV infection, a
fact which has been extensively exploited: HBsAg serves as the basis for
the diagnosis of HBV infection and also as the current vaccine against
HBV. HBsAg consists of a "nested" set of three proteins, referred to as
the S, M, and L proteins, each of which occurs in two forms due to
further post-translational modifications. The structure of these will be
determined following isolation of the protein from naturally infected
human plasma, or following expression of the relevant protein by cloned
viral DNA in eukaryotic or prokaryotic expression vectors, using a
combination of physical (circular dichroism, FTIR, mass spectrometry,
ultracentrifugation), chemical (Edman degradation, carboxypeptidase
digestion, reduction and alkylation), and immunological (monoclonal
antibody binding studies, studies of immunogenicity) techniques. The
function of each of these proteins as binding proteins to cell receptors
and polymerized albumin will be examined. The antigenic activity of
these proteins will be examined by site specific mutagenesis, chemical
modification, use of anti- synthetic peptide and monoclonal antibodies.
The second goal of this project will be to utilize the information
gained from the above studies to identify specific antigenic domains of
the surface proteins (S,M, and L) for incorporation into novel chimeric
proteins containing the cholera B toxin subunit for investigation as a
potential oral immunogen against HBV. This will be done utilizing
synthetic DNA fused to the Cholera B subunit gene, and expression by
appropriate prokaryotic expression vectors.
本项目的第一个目标是确定
B型肝炎病毒的表面蛋白,称为B型肝炎
表面抗原(HBsAg),并确定它们之间的关系
结构和功能都是必需的病毒蛋白质,
是预防病毒性疾病的重要宿主靶点。 HBsAg是
在HBV感染的正常过程中大量产生,
已被广泛利用的事实:HBsAg作为
乙肝病毒感染的诊断,也作为目前的疫苗,
乙肝病毒。 HBsAg由一组“嵌套”的三种蛋白质组成,称为
S、M和L蛋白,每种蛋白都有两种形式,
进一步的翻译后修饰。 其结构将是
在从天然感染的病毒中分离蛋白质后测定,
人血浆,或通过克隆表达相关蛋白质后
真核或原核表达载体中的病毒DNA,使用
物理(圆二色性,FTIR,质谱,
超离心)、化学(Edman降解、羧肽酶
消化、还原和烷基化)和免疫学(单克隆
抗体结合研究、免疫原性研究)技术。 的
这些蛋白质中的每一种作为细胞受体的结合蛋白的功能
和聚合白蛋白。 的抗原活性
这些蛋白质将通过位点特异性诱变、化学诱变和免疫荧光法进行检测。
修饰,使用抗合成肽和单克隆抗体。
该项目的第二个目标是利用信息
从上述研究中获得,以鉴定
用于掺入新嵌合体的表面蛋白(S、M和L)
含有霍乱B毒素亚单位的蛋白质,
抗HBV的潜在口服免疫原。 这将通过使用
与霍乱B亚单位基因融合的合成DNA,并通过
合适的原核表达载体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darrell L Peterson其他文献
Darrell L Peterson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darrell L Peterson', 18)}}的其他基金
相似海外基金
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10685312 - 财政年份:2021
- 资助金额:
$ 11.76万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10490872 - 财政年份:2021
- 资助金额:
$ 11.76万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10345963 - 财政年份:2021
- 资助金额:
$ 11.76万 - 项目类别:
Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy
开发高功能化血清白蛋白作为硼输送至肿瘤以进行中子捕获治疗
- 批准号:
17H02202 - 财政年份:2017
- 资助金额:
$ 11.76万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on Asymmetric Nitroaldol Reaction using mutant albumins
突变体白蛋白不对称硝醛醇反应的研究
- 批准号:
16K05706 - 财政年份:2016
- 资助金额:
$ 11.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SPIN LABELING STUDIES OF NORMAL RECOMBINANT & MUTANT HUMAN SERUM ALBUMINS
正常重组的旋转标记研究
- 批准号:
6118869 - 财政年份:1999
- 资助金额:
$ 11.76万 - 项目类别:
COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS
商业、正常重组的铜结合,
- 批准号:
6118864 - 财政年份:1999
- 资助金额:
$ 11.76万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia in Fowl
家禽双清蛋白血症血清白蛋白的结构与代谢特征
- 批准号:
67B6472 - 财政年份:1967
- 资助金额:
$ 11.76万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia
双清蛋白血症血清白蛋白的结构和代谢特征
- 批准号:
65B3344 - 财政年份:1965
- 资助金额:
$ 11.76万 - 项目类别: